To understand the mechanism by which Kir6.1 overexpression reduces cardiac dysfunction in DCM, the changes in the AKT‐FoxO1 signalling pathway were investigated in vivo and in vitro. This evidence concerns the gene KCNJ8 and familial dilated cardiomyopathy.